Madrigal Pharmaceuticals, Inc. (MDGL)

441.04 +1.04 (+0.24%) USD  |  NASDAQ  |  Feb 25, 09:31
More

Madrigal Pharmaceuticals Total Expenses (% of Quarterly Revenues)

Total Expenses (% of Quarterly Revenues) Chart

View Total Expenses (% of Quarterly Revenues) for MDGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Quarterly Revenues) Benchmarks

View Total Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Eli Lilly & Co. Upgrade
Insmed, Inc. Upgrade
Johnson & Johnson Upgrade
Crinetics Pharmaceuticals, Inc. Upgrade